Vicious circle of perceived stigma, enacted stigma and depressive symptoms among children affected by HIV/AIDS: A cross-lagged model
Methods: This study explores the longitudinal reciprocal effects of depressive symptoms and stigma, specifically enacted stigma and perceived stigma, among children affected by HIV/AIDS aged 6 to 12. Longitudinal data were collected from 272 children orphaned by AIDS and 249 children of HIV-positive parents in rural China. Cross-lagged panel analysis was conducted in the study.
Results: Results showed that the autoregressive effects were stable for depressive symptoms, perceived stigma and enacted stigma suggesting the substantially stable individual differences over time. The cross-lagged effects indicated a vicious circle among the three variables in an order of enacted stigma->depressive symptom->perceived stigma->enacted stigma. The possibility of employing equal constraints on cross-lagged paths suggested that the cross-lagged effects were repeatable over time.
Conclusion: The dynamic interplay of enacted stigma, perceived stigma and depressive symptoms suggest the need of a multilevel intervention in stigma reduction programming to promote mental health of children affected by HIV/AIDS.
Learning Areas:Social and behavioral sciences
Identify a vicious circle among stigma and depressive symptoms by cross-lagged analyses Describe the predicting pattern in an order of enacted stigma->depressive symptoms->perceived stigma->enacted stigma Demonstrate the need to consider the interplay of various components of stigma in mental health promotion
Keyword(s): HIV/AIDS, Child and Adolescent Mental Health
Qualified on the content I am responsible for because: I am working as research assistant in the Prevention Research Center, Wayne State University School of Medicine. I assisted with the project on children affected by HIV/AIDS.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.